# PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension

> **NCT07368088** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension (PAH)
- Premature Infants

## Interventions

- **BIOLOGICAL:** PNEUMOSTEM®

## Key facts

- **NCT ID:** NCT07368088
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-12
- **Final completion:** 2027-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07368088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07368088, "PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07368088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*